108 related articles for article (PubMed ID: 31305195)
21. Autologous hematopoietic cell transplantation for acute myeloid leukemia in adults: 25 years of experience in Japan.
Yanada M; Takami A; Mizuno S; Mori J; Chou T; Usuki K; Uchiyama H; Amano I; Fujii S; Miyamoto T; Saito T; Kamimura T; Ichinohe T; Fukuda T; Okamoto S; Atsuta Y; Yano S
Int J Hematol; 2020 Jan; 111(1):93-102. PubMed ID: 31612307
[TBL] [Abstract][Full Text] [Related]
22. Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience.
Kelaidi C; Chevret S; De Botton S; Raffoux E; Guerci A; Thomas X; Pigneux A; Lamy T; Rigal-Huguet F; Meyer-Monard S; Chevallier P; Maloisel F; Deconinck E; Ferrant A; Fegueux N; Ifrah N; Sanz M; Dombret H; Fenaux P; Adès L
J Clin Oncol; 2009 Jun; 27(16):2668-76. PubMed ID: 19414681
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics and outcome of childhood acute promyelocitic leukemia (APL) in Saudi Arabia: a multicenter SAPHOS leukemia group study.
Jastaniah W; Alsultan A; Al Daama S; Ballourah W; Bayoumy M; Al-Anzi F; Al Shareef O; Abrar MB; Al Sudairy R; Al Ghemlas I
Hematology; 2018 Jul; 23(6):316-323. PubMed ID: 29212418
[TBL] [Abstract][Full Text] [Related]
24. Epidemiological Trends of Head and Neck Cancer: A Population-Based Study.
Guo K; Xiao W; Chen X; Zhao Z; Lin Y; Chen G
Biomed Res Int; 2021; 2021():1738932. PubMed ID: 34337000
[TBL] [Abstract][Full Text] [Related]
25. Long-term follow-up of children with acute promyelocytic leukemia treated with Beijing Children's Hospital APL 2005 protocol (BCH-APL 2005).
Zhang Y; Wang L; Zhang R; Qi P; Xie J; Shi H; Lin W; Wu Y; Yu J; Fan J; Feng G; Zheng H; Wu M
Pediatr Hematol Oncol; 2019 Oct; 36(7):399-409. PubMed ID: 31530209
[TBL] [Abstract][Full Text] [Related]
26. Arsenic trioxide-based therapy is suitable for patients with psoriasis-associated acute promyelocytic leukemia - A retrospective clinical study.
Ge F; Zhang Y; Cao F; Li J; Hou J; Wang P; Li H; Xu M; Liu S; Li L; Li X; Wang S; Lv C; Su Y; Zhou J
Hematology; 2016 Jun; 21(5):287-94. PubMed ID: 26871996
[TBL] [Abstract][Full Text] [Related]
27. Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group.
Braun T; Cereja S; Chevret S; Raffoux E; Beaumont M; Detourmignies L; Pigneux A; Thomas X; Bordessoule D; Guerci A; Lamy T; Recher C; Poiré X; Tournilhac O; Spertini O; Chomienne C; Degos L; Dombret H; Adès L; Fenaux P;
Cancer; 2015 Jul; 121(14):2393-9. PubMed ID: 25845577
[TBL] [Abstract][Full Text] [Related]
28. Characteristics and prognosis analysis of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide as the front-line therapy.
Lou Y; Suo S; Tong H; Ye X; Wang Y; Chen Z; Qian W; Meng H; Mai W; Huang J; Tong Y; Jin J
Leuk Res; 2013 Nov; 37(11):1451-6. PubMed ID: 23958062
[TBL] [Abstract][Full Text] [Related]
29. Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death.
Altman JK; Rademaker A; Cull E; Weitner BB; Ofran Y; Rosenblat TL; Haidau A; Park JH; Ram SL; Orsini JM; Sandhu S; Catchatourian R; Trifilio SM; Adel NG; Frankfurt O; Stein EM; Mallios G; Deblasio T; Jurcic JG; Nimer S; Peterson LC; Kwaan HC; Rowe JM; Douer D; Tallman MS
Leuk Res; 2013 Sep; 37(9):1004-9. PubMed ID: 23768930
[TBL] [Abstract][Full Text] [Related]
30. The global problem of early deaths in acute promyelocytic leukemia: A strategy to decrease induction mortality in the most curable leukemia.
Jillella AP; Kota VK
Blood Rev; 2018 Mar; 32(2):89-95. PubMed ID: 29033137
[TBL] [Abstract][Full Text] [Related]
31. The Epidemiological Trend of Acute Myeloid Leukemia in Childhood: a Population-Based Analysis.
Chen X; Pan J; Wang S; Hong S; Hong S; He S
J Cancer; 2019; 10(20):4824-4835. PubMed ID: 31598153
[TBL] [Abstract][Full Text] [Related]
32. Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low-middle-income country.
Lins MM; Mello MJG; Ribeiro RC; De Camargo B; de Fátima Pessoa Militão de Albuquerque M; Thuler LCS
Ann Hematol; 2019 Jun; 98(6):1403-1411. PubMed ID: 30915498
[TBL] [Abstract][Full Text] [Related]
33. Treatment of de novo acute myeloid leukemia in the United States: a report from the Patterns of Care program.
Doria-Rose VP; Harlan LC; Stevens J; Little RF
Leuk Lymphoma; 2014 Nov; 55(11):2549-55. PubMed ID: 24467221
[TBL] [Abstract][Full Text] [Related]
34. [An epidemiological investigation of adult acute leukemia in Fujian Province in 2010].
Clinical Collaborative Group, Hematological Branch of Fujian Medical Association
Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):902-5. PubMed ID: 23363744
[TBL] [Abstract][Full Text] [Related]
35. Differences in childhood leukemia incidence and survival between Southern Thailand and the United States: a population-based analysis.
Demanelis K; Sriplung H; Meza R; Wiangnon S; Rozek LS; Scheurer ME; Lupo PJ
Pediatr Blood Cancer; 2015 Oct; 62(10):1790-8. PubMed ID: 25962869
[TBL] [Abstract][Full Text] [Related]
36. Trends in leukemia incidence and survival in the United States (1973-1998).
Xie Y; Davies SM; Xiang Y; Robison LL; Ross JA
Cancer; 2003 May; 97(9):2229-35. PubMed ID: 12712476
[TBL] [Abstract][Full Text] [Related]
37. Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.
Lucena-Araujo AR; Kim HT; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Chauffaille Mde L; Chiattone CS; Lima AS; Ruiz-Argüelles G; Undurraga MS; Martinez L; Kwaan HC; Gallagher R; Niemeyer CM; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM
Ann Hematol; 2014 Dec; 93(12):2001-10. PubMed ID: 24981688
[TBL] [Abstract][Full Text] [Related]
38. Childhood acute promyelocytic leukemia in Nicaragua.
Malta Corea A; Pacheco Espinoza C; Cantù Rajnoldi A; Conter V; Lietti G; Masera G; Sessa C; Cavalli F; Biondi A; Rovelli A
Ann Oncol; 1993 Dec; 4(10):892-4. PubMed ID: 8117610
[TBL] [Abstract][Full Text] [Related]
39. Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trials.
Micol JB; Raffoux E; Boissel N; Lengliné E; Canet E; Daniel MT; Labarthe Ad; Maarek O; Cassinat B; Adès L; Baruchel A; Degos L; Azoulay E; Dombret H
Eur J Cancer; 2014 Apr; 50(6):1159-68. PubMed ID: 24440088
[TBL] [Abstract][Full Text] [Related]
40. Acute undifferentiated leukemia: data on incidence and outcomes from a large population-based database.
Qasrawi A; Gomes V; Chacko CA; Mansour A; Kesler M; Arora R; Wei S; Ramlal R; Munker R
Leuk Res; 2020 Feb; 89():106301. PubMed ID: 31982153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
